SIM0278

· Jiangsu Simcere Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SIM0278, covering 2025-09-11 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis [Phase 2]